Ronald Andrews
2021
In 2021, Ronald Andrews earned a total compensation of $2.9M as Former President and Chief Executive Officer at Oncocyte Corp, a 179% increase compared to previous year.
Compensation breakdown
| Bonus | $297,600 |
|---|---|
| Option Awards | $2,120,000 |
| Salary | $480,000 |
| Other | $24,238 |
| Total | $2,921,838 |
Andrews received $2.1M in option awards, accounting for 73% of the total pay in 2021.
Andrews also received $297.6K in bonus, $480K in salary and $24.2K in other compensation.
Rankings
In 2021, Ronald Andrews' compensation ranked 4,525th out of 12,415 executives tracked by ExecPay. In other words, Andrews earned more than 63.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 4,525 out of 12,415 | 64th |
Division Manufacturing | 1,871 out of 5,508 | 66th |
Major group Chemicals And Allied Products | 778 out of 2,378 | 67th |
Industry group Drugs | 692 out of 2,099 | 67th |
Industry In Vitro and In Vivo Diagnostic Substances | 14 out of 61 | 77th |
Source: SEC filing on May 19, 2023.
Andrews' colleagues
We found one more compensation record of an executive who worked with Ronald Andrews at Oncocyte Corp in 2021.
2021
Douglas Ross
Oncocyte Corp